Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-05
2010-06-22
O'Sullivan, Peter G (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S424000, C514S524000, C514S597000, C514S605000, C548S214000, C548S550000, C558S413000, C564S049000, C564S099000
Reexamination Certificate
active
07741351
ABSTRACT:
This case discloses compounds of formula (I) wherein R1is C1-6alkyl, haloC1-6alkyl, C2-6alkenyl, amino, monoC1-4alkylamino or diC1-4alkylamino; R2and R3, which may be the same or different, are hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano or amino; each R4, which may be the same or different, is C1-6alkyl, halogen, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, nitro or amino; p is 0, 1 or 2; each R5, which may be the same or different, is C1-6alkyl, halogen, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, nitro or amino; q is 0, 1 or 2; R6is —NR6aSO2R6b, —NR6aC(═O)R6b, —NR6a(C═O)N(R6c)2, —(C═O)R6d, —CH2NR6aSO2R6b, —CH2NR6aC(═O)R6b, CH2NR6a(C═O)N(R6c)2or —CH2(C═O)R6d; where R6aand each R6c, which may be the same or different, is hydrogen or C1-6alkyl; R6band R6dare C1-6alkyl or haloC1-6alkyl; or R6aand R6b, or R6aand R6c, together with the interconnecting atoms, may form a 5- or 6-membered ring; n is 1 or 2; and R7and R8, which may be the same or different, are hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano or amino. It also discloses methods for preparing the compounds and their use in therapy such as treating schizophrenia.
REFERENCES:
patent: 6525099 (2003-02-01), Arnold et al.
patent: WO 00/06537 (2000-02-01), None
patent: WO 01/42203 (2001-06-01), None
Thewlis Kevin Michael
Ward Simon Edward
Gimmi Edward R.
Glaxo Group Limited
Kanagy James M.
Kinzig Charles M.
O'Sullivan Peter G
LandOfFree
Compounds which potentiate glutamate receptor and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds which potentiate glutamate receptor and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds which potentiate glutamate receptor and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4238433